Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
AROATXN2-1001
Phase 1 other active
Quick answer
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 for spinocerebellar ataxia type 2 is a Phase 1 program (other) at Arrowhead Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arrowhead Pharmaceuticals Ireland Limited
- Indication
- spinocerebellar ataxia type 2
- Phase
- Phase 1
- Modality
- other
- Status
- active